- Report
- July 2024
- 170 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- February 2024
- 140 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- February 2024
- 179 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- February 2024
- 115 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- February 2024
- 115 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- February 2024
- 110 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- February 2024
- 116 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- February 2024
- 115 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- February 2024
- 110 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- April 2023
- 110 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- April 2023
- 100 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- August 2022
- 115 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- January 2022
- 90 Pages
Europe
From €4231EUR$4,750USD£3,659GBP
- Report
- July 2021
- 120 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- February 2024
- 115 Pages
Global
From €4231EUR$4,750USD£3,659GBP
- Report
- December 2022
- 190 Pages
Global
From €3963EUR$4,450USD£3,428GBP
- Report
- January 2024
- 200 Pages
Global
From €3696EUR$4,150USD£3,197GBP
- Report
- October 2023
- 145 Pages
Global
From €2806EUR$3,150USD£2,427GBP
- Report
- February 2023
- 118 Pages
From €3073EUR$3,450USD£2,658GBP
- Report
- February 2023
- 107 Pages
Middle East, Africa
From €3073EUR$3,450USD£2,658GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more